Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.7001
Delayed Data
As of Jan 20
 -0.0641 / -8.39%
Today’s Change
0.51
Today|||52-Week Range
1.59
+10.32%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close0.76
Today’s open0.80
Day’s range0.70 - 0.84
Volume186,913
Average volume (3 months)20,174
Market cap$9.6M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.07-4.98%
BVXVBiondVax Pharmaceuti...-0.04-0.87%
CYANCyanotech Corp+0.15+3.52%
EVOKEvoke Pharma Inc-0.02-0.78%
Data as of 3:59pm ET, 01/20/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs